Publications dans lesquelles il/elle collabore avec ANDRES MANUEL R CERVANTES RUIPEREZ (9)

2021

  1. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 22, Núm. 1, pp. 29-42

  2. Trends and outcome of neoadjuvant treatment for rectal cancer: A retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project

    European Journal of Surgical Oncology, Vol. 47, Núm. 2, pp. 276-284

2020

  1. Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer

    ESMO Open, Vol. 5, Núm. 5

  2. Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a prospective database

    Gastroenterologia y Hepatologia, Vol. 43, Núm. 2, pp. 63-72

2019

  1. Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression

    Modern Pathology, Vol. 32, Núm. 2, pp. 306-313

  2. Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 30, Núm. 11, pp. 1804-1812

2018

  1. Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score

    Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. 104-112.e2

2017

  1. Stents metálicos autoexpandibles como puente a la cirugía en el tratamiento del cáncer de colon izquierdo en oclusión. Análisis coste-beneficio y resultados oncológicos

    Cirugia Espanola, Vol. 95, Núm. 3, pp. 143-151

2015

  1. Selective approach for upper rectal cancer treatment: Total mesorectal excision and preoperative chemoradiation are seldom necessary

    Diseases of the Colon and Rectum, Vol. 58, Núm. 6, pp. 556-565